Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human mesenchymal stem cells modulate allogeneic immune cell responses.

Sudeepta Aggarwal1, Mark F Pittenger

  • 1Osiris Therapeutics, 2001 Aliceanna St, Baltimore, MD 21231, USA.

Blood
|October 21, 2004
PubMed
Summary

Human mesenchymal stem cells (hMSCs) modulate immune cells, promoting tolerance by altering cytokine profiles and increasing regulatory T cells. Prostaglandin E2 (PGE2) mediates these immune-suppressive effects, offering therapeutic potential for graft-versus-host disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19.

Journal of clinical pharmacology·2023
Same author

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19.

Open forum infectious diseases·2023
Same author

Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study.

The British journal of dermatology·2023
Same author

Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.

The British journal of dermatology·2022
Same author

MSC Pretreatment for Improved Transplantation Viability Results in Improved Ventricular Function in Infarcted Hearts.

International journal of molecular sciences·2022
Same author

ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.

Nature medicine·2021

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Transplantation Medicine

Background:

  • Mesenchymal stem cells (MSCs) are multipotent cells with observed immune-evasive properties in allogeneic transplantation.
  • MSCs show potential in reducing graft-versus-host disease (GVHD), but the underlying mechanisms require elucidation.

Purpose of the Study:

  • To investigate the immunomodulatory functions of human MSCs (hMSCs) on various immune cell subpopulations.
  • To elucidate the mechanisms by which hMSCs induce immune tolerance, potentially for therapeutic applications.

Main Methods:

  • Co-culturing hMSCs with purified immune cells, including dendritic cells (DCs), T helper 1 (T(H)1) and T helper 2 (T(H)2) cells, and natural killer (NK) cells.
  • Analyzing changes in cytokine secretion profiles (TNF-alpha, IL-10, IFN-gamma, IL-4) and regulatory T cell (T(Reg)) populations.

Related Experiment Videos

  • Investigating the role of prostaglandin E2 (PGE(2)) by using inhibitors and assessing its impact on hMSC-mediated immune modulation.

    • Main Results:

    • hMSCs altered cytokine secretion in DCs, T cells, and NK cells, promoting an anti-inflammatory or tolerant phenotype.
    • hMSCs increased the proportion of regulatory T cells (T(Regs)) and decreased pro-inflammatory cytokine production (e.g., TNF-alpha, IFN-gamma).
    • Elevated prostaglandin E2 (PGE(2)) production by hMSCs was identified as a key mediator of their immunomodulatory effects.

    Conclusions:

    • hMSCs possess significant immunomodulatory capabilities, shifting immune cell responses towards tolerance.
    • PGE(2) plays a crucial role in mediating the immune-suppressive functions of hMSCs.
    • These findings provide mechanistic insights into hMSC-mediated tolerance, supporting their therapeutic potential for GVHD, transplant rejection, and inflammatory conditions.